IRA Policy Changes: Planning for Life Sciences
To learn more about how Avalere can support your organization, please connect with us. The post IRA Policy Changes: Planning for Life Sciences appeared first on Avalere.
View ArticleEvidence and Value Under the Inflation Reduction Act
To watch the full Outlook 2023 webinar recording, visit avalere.com/outlook. The post Evidence and Value Under the Inflation Reduction Act appeared first on Avalere.
View ArticleIRA Impacts on Patient Access
If you’d like to learn more, connect with us at Asembia. The post IRA Impacts on Patient Access appeared first on Avalere.
View ArticleIRA Impacts on Evidence and Strategy
If you’d like to learn more, connect with us at the upcoming Asembia and ISPOR conferences. The post IRA Impacts on Evidence and Strategy appeared first on Avalere.
View ArticleInnovations in Kidney Care
The post Innovations in Kidney Care appeared first on Avalere.
View ArticleCongressional Debate Over PBM Legislation
The post Congressional Debate Over PBM Legislation appeared first on Avalere.
View ArticleRSV Prevention, Part V: Where Are We Now?
The post RSV Prevention, Part V: Where Are We Now? appeared first on Avalere.
View ArticleUnderstanding the Medicaid Drug Rebate Program Proposed Rule
The post Understanding the Medicaid Drug Rebate Program Proposed Rule appeared first on Avalere.
View ArticleNavigating Major Policy Changes: Insights for Medicare Advantage Plans
The post Navigating Major Policy Changes: Insights for Medicare Advantage Plans appeared first on Avalere.
View ArticlePatient Support Perspective for 2023 and Beyond
The post Patient Support Perspective for 2023 and Beyond appeared first on Avalere.
View ArticleUnpacking the Implications of the Negotiated Drug List, Part 1
The post Unpacking the Implications of the Negotiated Drug List, Part 1 appeared first on Avalere.
View ArticleSpotlight on Avalere’s Evidence and Strategy Practice
The post Spotlight on Avalere’s Evidence and Strategy Practice appeared first on Avalere.
View ArticleClik here to view.
Unpacking the Implications of the Negotiated Drug List, Part 2
In case you missed it, watch Unpacking the Implications of the Negotiated Drug List, Part 1. Sign up to view Part 2. The post Unpacking the Implications of the Negotiated Drug List, Part 2 appeared...
View ArticleMaximizing Access & Uptake for Digital Health Technologies
Featured Speakers: Leah Carlisle, Senior Healthcare Consultant: Strategy, Experience & Engagement, Fishawack Health Shelby Harrington, Principal, Evidence and Strategy Zachary Klein, Consultant I,...
View ArticleClik here to view.
2023 Top Trends in Health Economics and Outcomes Research
Sign up to view the 2023 Top Trends in Health Economics and Outcomes Research video. To learn more about this series, visit our insight page. The post 2023 Top Trends in Health Economics and...
View ArticleEmbedding Patient-Centric Principles in Research, Quality, and Care Delivery
The post Embedding Patient-Centric Principles in Research, Quality, and Care Delivery appeared first on Avalere.
View ArticleContextualizing AI for HEOR in 2023
The post Contextualizing AI for HEOR in 2023 appeared first on Avalere.
View ArticleReevaluating Value Assessment for HEOR in 2023
The post Reevaluating Value Assessment for HEOR in 2023 appeared first on Avalere.
View ArticleHEOR as a Differentiator Versus a Commodity
The post HEOR as a Differentiator Versus a Commodity appeared first on Avalere.
View ArticlePolicy’s Pressure on HEOR
The post Policy’s Pressure on HEOR appeared first on Avalere.
View Article